Table 1. Patients’ data.
| Group C (n = 13) | Group S (n = 13) | P-value | |
|---|---|---|---|
| Age* | 47.2 ± 10.9 | 57.8 ± 13.2 | 0.04 |
| Gender (male:female) | 8:5 | 9:4 | >0.99 |
| Body surface area (m2) | 1.70 ± 0.22 | 1.64 ± 0.19 | 0.59 |
| Body mass index | 21.8 ± 4.1 | 20.3 ± 3.3 | 0.40 |
| Hypertension | 4 (30.8) | 8 (61.5) | 0.24 |
| Dyslipidemia | 2 (15.4) | 5 (38.5) | 0.38 |
| Diabetes mellitus | 1 (7.7) | 0 | >0.99 |
| Smoking history | 8 (61.5) | 4 (30.8) | 0.24 |
| Chronic atrial fibrillation | 0 | 1 (7.7) | >0.99 |
| NYHA III, IV | 0 | 2 (15.4) | 0.48 |
| Left ventricular ejection fraction (%) | 69.2 ± 4.9 | 70.1 ± 6.9 | 0.68 |
| Tricuspid valve annuloplasty (+) | 1 (7.7) | 3 (23.1) | 0.59 |
| Pulmonary vein isolation (+) | 0 | 2 (15.4) | 0.48 |
| Atrial septal defect closure (+) | 0 | 1 (7.7) | >0.99 |
| Operation time (minutes) | 386.3 ± 59.6 | 380.4 ± 64.4 | 0.82 |
| Average NRS* | 2.40 ± 1.46 | 0.82 ± 0.49 | <0.01 |
| Maximum NRS* | 5.69 ± 2.43 | 3.23 ± 1.17 | <0.01 |
| Additional analgesics (+)* | 11 (84.6) | 3 (23.1) | <0.01 |
| Additional analgesics frequency (/patient)* | 2.38 ± 1.85 | 0.23 ± 0.44 | <0.01 |
Values are direct number or mean ± standard deviation, and values in parentheses are percentages
*Significant difference between Groups C and S
NYHA: New York Heart Association functional class; NRS: numerical rating scale